COVID-19 infection and vaccination in immunodeficiency

Clin Exp Immunol. 2022 Sep 29;209(3):259-261. doi: 10.1093/cei/uxac080.

Abstract

During the last 2 years and a half, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide, causing about 6 million deaths. Clinical manifestations are highly variable, ranging from entirely asymptomatic infection to multiorgan failure and death. The outcome in immunocompromised patients is still a matter of debate, and so are the optimal strategies to prevent or treat the infection in these high-risk populations.

Keywords: immunodeficiency diseases; infection; vaccination; virus.

MeSH terms

  • Asymptomatic Infections
  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2
  • Vaccination